CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Common Stock	Accumulated Deficit
Balance, beginning of period at Feb. 01, 2020	$ 76,955	$ 172,885	$ (95,930)
Balance, beginning of period (in shares) at Feb. 01, 2020		13,955,826
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Employee stock purchases	35	$ 35
Employee stock purchases (in shares)		34,999
Restricted stock issued		32,341
Net share settlement of stock options and restricted stock units	(8)	$ (8)
Net share settlement of stock options and restricted stock units (in shares)		(8,663)
Stock-based compensation expense	307	$ 307
Net income (loss)	(7,438)		(7,438)
Balance, end of period at May. 02, 2020	69,851	$ 173,219	(103,368)
Balance, end of period (in shares) at May. 02, 2020		14,014,503
Balance, beginning of period at Feb. 01, 2020	76,955	$ 172,885	(95,930)
Balance, beginning of period (in shares) at Feb. 01, 2020		13,955,826
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	$ 12
Repurchase and retirement of common stock (in shares)	0
Net income (loss)	$ (4,445)
Balance, end of period at Oct. 31, 2020	$ 73,417	$ 173,792	(100,375)
Balance, end of period (in shares) at Oct. 31, 2020	14,255,596	14,255,596
Balance, beginning of period at May. 02, 2020	$ 69,851	$ 173,219	(103,368)
Balance, beginning of period (in shares) at May. 02, 2020		14,014,503
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock issued		230,688
Net share settlement of stock options and restricted stock units	(5)	$ (5)
Net share settlement of stock options and restricted stock units (in shares)		(5,110)
Stock-based compensation expense	329	$ 329
Net income (loss)	(9,363)		(9,363)
Balance, end of period at Aug. 01, 2020	60,812	$ 173,543	(112,731)
Balance, end of period (in shares) at Aug. 01, 2020		14,240,081
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	12	$ 12
Exercise of stock options (in shares)		1,464
Restricted stock issued		18,575
Net share settlement of stock options and restricted stock units	(39)	$ (39)
Net share settlement of stock options and restricted stock units (in shares)		(4,524)
Stock-based compensation expense	$ 276	$ 276
Repurchase and retirement of common stock (in shares)	0
Net income (loss)	$ 12,356		12,356
Balance, end of period at Oct. 31, 2020	$ 73,417	$ 173,792	(100,375)
Balance, end of period (in shares) at Oct. 31, 2020	14,255,596	14,255,596
Balance, beginning of period at Jan. 30, 2021	$ 94,922	$ 174,391	(79,469)
Balance, beginning of period (in shares) at Jan. 30, 2021	14,292,250	14,292,250
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	$ 52	$ 52
Exercise of stock options (in shares)		10,669
Restricted stock issued		30,087
Net share settlement of stock options and restricted stock units	(257)	$ (257)
Net share settlement of stock options and restricted stock units (in shares)		(11,339)
Stock-based compensation expense	232	$ 232
Repurchase and retirement of common stock	(1,356)		(1,356)
Repurchase and retirement of common stock (in shares)		(47,350)
Net income (loss)	1,719		1,719
Balance, end of period at May. 01, 2021	95,312	$ 174,418	(79,106)
Balance, end of period (in shares) at May. 01, 2021		14,274,317
Balance, beginning of period at Jan. 30, 2021	$ 94,922	$ 174,391	(79,469)
Balance, beginning of period (in shares) at Jan. 30, 2021	14,292,250	14,292,250
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	$ 146
Repurchase and retirement of common stock (in shares)	(1,414,642)
Net income (loss)	$ 9,574
Balance, end of period at Oct. 30, 2021	$ 75,763	$ 175,479	(99,716)
Balance, end of period (in shares) at Oct. 30, 2021	13,007,409	13,007,409
Balance, beginning of period at May. 01, 2021	$ 95,312	$ 174,418	(79,106)
Balance, beginning of period (in shares) at May. 01, 2021		14,274,317
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options	94	$ 94
Exercise of stock options (in shares)		20,168
Restricted stock issued		79,775
Net share settlement of stock options and restricted stock units	(73)	$ (73)
Net share settlement of stock options and restricted stock units (in shares)		(7,582)
Stock-based compensation expense	651	$ 651
Repurchase and retirement of common stock	(12,008)		(12,008)
Repurchase and retirement of common stock (in shares)		(561,548)
Net income (loss)	626		626
Balance, end of period at Jul. 31, 2021	84,602	$ 175,090	(90,488)
Balance, end of period (in shares) at Jul. 31, 2021		13,805,130
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock issued		10,606
Net share settlement of stock options and restricted stock units	(49)	$ (49)
Net share settlement of stock options and restricted stock units (in shares)		(2,583)
Stock-based compensation expense	438	$ 438
Repurchase and retirement of common stock	$ (16,457)		(16,457)
Repurchase and retirement of common stock (in shares)	(805,744)	(805,744)
Net income (loss)	$ 7,229		7,229
Balance, end of period at Oct. 30, 2021	$ 75,763	$ 175,479	$ (99,716)
Balance, end of period (in shares) at Oct. 30, 2021	13,007,409	13,007,409